Veterinary Orthopedic Medicines Market (2026 - 2033)

Veterinary Orthopedic Medicines Market Summary

The global veterinary orthopedic medicines market size was valued at USD 2.0 billion in 2025 and is projected to grow from USD 2.1 billion in 2026 to USD 3.8 billion by 2033, at a CAGR of 8.6% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 40.5% in 2025. The growth can be attributed to rising prevalence of orthopedic disorders in animals, the growing uptake of pet insurance, an increase in the aging animal population, and advancements in veterinary orthopedic medicines.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Orthopedic issues can negatively impact an animal's quality of life by affecting the bones, muscles, and joints. Canine dysplasia of the elbow & hips and arthritis are among common conditions. Several factors contribute to orthopedic problems in animals, including aging, poor diet, and obesity.

Recent studies have shown a rise in obesity among animals such as dogs and horses. Stem cell therapy has recently gained popularity and generated significant interest in research & clinical settings. In veterinary medicine, stem cell therapy has been studied as a potential treatment option for various health complications such as dermatological, orthopedic, dental, etc. The use of stem cells in these diseases is still in its infancy, but the potential for stem cell therapy in veterinary medicine is extensive. The veterinary orthopedic medicines market is growing due to increase in prevalence of Osteoarthritis (OA) and other Degenerative Joint Diseases (DJD) among various animals like dogs, cats, & horses, among others.

OA affects the performance and wellbeing of athletic horses. For early diagnosis, it is important to understand causal & developmental pathways and prescribe the right treatment. Moreover, several pet owners are opting for pet insurance to manage the health expenses of their pets. According to survey conducted by Rover in 2026, pet parents of medium-sized dog breeds spend between USD 145 to USD 505 per month. The cost of pet parenting has gone up by 15% compared to 2025.

Analyst Perspective

The veterinary orthopedic medicines market is being driven by the increasing incidence of orthopedic disorders and musculoskeletal injuries in companion animals, along with the growing demand for advanced veterinary care. A key opportunity lies in the development of targeted pain management therapies, regenerative medicine, and long-acting orthopedic treatments that improve mobility and recovery in animals. The pharmaceuticals market is growing consistently due to the widespread use of anti-inflammatory drugs, analgesics, and other medications for managing orthopedic conditions before and after surgical procedures. The developed market of North America and Europe is supported by high pet ownership, advanced veterinary healthcare infrastructure, increasing spending on animal health, and growing awareness of orthopedic disease management. These factors continue to drive market growth and support innovation in veterinary orthopedic therapeutics.

Product Insights

By product, the pharmaceuticals product segment accounted for the largest market revenue share of approximately 46.5% in 2025. This high percentage can be attributed to the fact that pharmaceuticals are the first line of treatment for any musculoskeletal disorder in animals. They are available in various dosage forms, such as tablets, chewable tablets, powders, liquids, and creams/ointments, and can therefore be used as needed across various species. Several emerging companies are developing generic versions of pharmaceutical products such as NSAIDs and steroids to ensure widespread availability for animal owners. For instance, in April 2024, VetStem, Inc. launched PrecisePRP Canine, an off-the-shelf PRP product designed for intra-articular administration in dogs. This freeze-dried PRP does not require blood draw or centrifugation and offers consistent dosage & reduced safety risks through FDA-approved quality testing.

The viscosupplements segment is expected to register the fastest CAGR of 9.5% over the forecast period. Viscosupplements, such as hyaluronic acid & polyacrylamide hydrogel, improve joint function by lubricating, lowering friction, and stabilizing the joint structure. Their main purpose is to reduce pain, ease lameness, and minimize joint degeneration to manage & enhance the orthopedic health of equine athletes. These hyaluronic acid-based products are administered directly into the joints (intra-articular), mainly in animals like dogs & horses, to improve joint functioning.

Animal Type Insights

By animal type, the canine segment accounted for the largest market revenue share of approximately 46.0% in 2025. This can be attributed to the growing prominence of dog adoption globally. A research article published in the Journal of Small Animal Practice (JSAP) suggested that musculoskeletal disorders such as OA and DJD affect approximately 200,000 dogs annually.

The other animal type segment is expected to register the fastest CAGR of approximately 10.0% over the forecast period. In animals like swine and cattle, NSAIDs & steroids are most widely used for the treatment of orthopedic conditions. However, research is underway for applying biologics treatment in these species. In cats, despite the high prevalence of orthopedic conditions such as OA, i.e., more than 50%, the adoption of treatment is very low. However, this is expected to change with the evolving industry landscape and the growing popularity of cats. Expenditure on cat health is anticipated to increase, leading to a rising focus on treating OA that will boost the demand for orthopedic medications.

Application Insights

By application, the osteoarthritis segment accounted for the largest market revenue share of approximately 60.5% in 2025. This can be attributed to the fact that OA is the most common musculoskeletal disorder in animals. This disease is debilitating and causes inflammation of the joints. It is often extremely painful and leads to lameness as well as postural & behavioral changes in animals like dogs, cats, horses, & cattle, among others.

The others application segment is expected to register the fastest CAGR over the forecast period. The others segment includes muscle strains, ligament tears, intervertebral disc syndrome, and trauma. To address these problems, veterinarians must employ various specialized interventions, including physical therapy, surgical procedures, and customized therapeutic measures. This section highlights the necessity for comprehensive strategies for successfully managing numerous diseases impacting the musculoskeletal condition of dogs and horses.

Route Of Administration Insights

By route of administration, the injectable route segment accounted for the largest market revenue share of approximately 59.5% in 2025. This is due to the wide availability of products administered through this route. Injectable medication has a higher absorption rate and leads to a faster onset of action in the animal's body, making it the most convenient method. In addition, the demand for injectable medications to treat orthopedic conditions holistically is increasing, with intra-articular injections specifically targeting joint issues and Intramuscular (IM) injections being particularly beneficial for alleviating pain, employing biologic drugs, anti-inflammatory drugs, & antibiotic therapy.

The IM segment under the injectable route is estimated to grow at the highest CAGR during the forecast period. IM administration is an effective form of medication delivery in veterinary orthopedic medicines. It is particularly beneficial for drug delivery of pain management drugs, anti-inflammatory drugs, muscle relaxation drugs, antibiotic therapy, and nutritional support.

End Use Insights

By end use, the veterinary hospitals segment accounted for the largest market revenue share in 2025. This can be attributed to the growing patient footfall in these hospitals. Moreover, biologics & viscosupplements need specific tools and skilled personnel to perform procedures. In addition, veterinarians prescribe medications based on each patient’s distinctive treatment plan, and hospitals stock these medications so pet owners can get them easily.

The veterinary clinics segment is anticipated to witness a substantial growth due to higher accessibility for animal owners. Large veterinary hospitals are only present at specific locations central to all. But, for most individuals, visiting a local veterinary clinic is more beneficial for basic needs such as medication procurement and routine animal check-ups.

Regional Insights

The North America veterinary orthopedic medicines market accounted for the largest market share of approximately 40.5% in 2025. This high share can be attributed to developed veterinary care infrastructure, high pet adoption, and the presence of major market players such as Zoetis & Elanco Animal Health in the U.S.

To learn more about this report, Download Free Sample Report

U.S. Veterinary Orthopedic Medicines Market Trends

The veterinary orthopedic medicines market in the U.S. is anticipated to witness significant growth of 7.8% CAGR over the forecast period due to the rising prevalence of OA and other degenerative joint diseases. Moreover, initiatives like product approval and launching new products play a significant role in driving growth within the veterinary orthopedic medicines market. For instance, in February 2025, Zoetis Inc. announced an updated U.S. label for Librela (bedinvetmab injection) following FDA review of post-approval data. Zoetis also reported that more than one million dogs in the U.S. had been treated with Librela since its U.S. launch.

Europe Veterinary Orthopedic Medicines Market Trends

The veterinary orthopedic medicines market in Europe was identified as a lucrative region in veterinary orthopedic medicines market. Europe held the second-largest share of the veterinary orthopedic medicines market in 2025. The increasing number of pets across Europe and growing pet humanization trends drive the demand for advanced veterinary orthopedic services. Pets are increasingly considered as family members, leading to higher spending on their healthcare needs, including orthopedic care. Pet owners are becoming more aware of the available treatment options for their pets, including orthopedic procedures.

The veterinary orthopedic medicines market in the UK is anticipated to witness significant growth over the forecast period due to factors such as rising consumer awareness of pet insurance and the need to purchase dog & cat insurance.

The veterinary orthopedic medicines market in Germany is expected to grow over the forecast period. Germany has a large population of horses, with a significant percentage involved in activities like sports, racing, and leisure riding. Increased activity increases orthopedic injuries and illnesses in equines. German veterinarians adhere to high standards of care, ensuring that equine orthopedic conditions are diagnosed accurately and treated effectively. This commitment to quality care contributes to the overall growth of the orthopedic medicine market

Asia Pacific Veterinary Orthopedic Medicines Market Trends

The veterinary orthopedic medicines market in Asia Pacific is anticipated to witness the highest CAGR over the forecast period. With a growing middle-class population and increased disposable income, pet owners in the Asia Pacific region are becoming more aware of the importance of maintaining their pet's health & wellbeing.

The veterinary orthopedic medicines market in Japan is expected to grow over the forecast period. This can be attributed to the presence of veterinary hospitals, which serve as crucial centers for providing medical care to animals, including orthopedic procedures. Moreover, veterinary hospitals often collaborate with other healthcare providers, including specialists in orthopedic medicine. This collaborative network enhances the availability and accessibility of orthopedic services, boosting market growth.

Latin America Veterinary Orthopedic Medicines Market Trends

The veterinary orthopedic medicines market in Latin America exhibits lack of awareness among pet owners about the importance of managing pet obesity, which is a significant problem. Furthermore, increased government funding has contributed to the market growth in countries like Brazil. Factors such as untapped opportunities, economic development, and rising awareness levels can contribute to rapid market growth of the region.

The Brazil veterinary orthopedic medicines market may attract international pharmaceutical companies seeking to expand their product portfolios and tap into the growing demand for advanced veterinary care in the country, driving growth. The increasing occurrence of orthopedic diseases in athletic bulls is likely to fuel the veterinary orthopedic medicines market as owners and breeders seek ways to ensure the health & performance of their animals.

Middle East And Africa Veterinary Orthopedic Medicines Market Trends

South Africa, Saudi Arabia, Kuwait, and the United Arab Emirates are part of the MEA region. Due to growing awareness and a high incidence of conditions like hip dysplasia, degenerative disc disease, torn cruciate ligaments, fractures, arthritis, & others, the veterinary orthopedic medicines market in this region is expected to grow during the forecast period.

The veterinary orthopedic medicines market in the UAE is expected to grow due to the availability of pet insurance and a growing number of wellness initiatives. An increasing number of pet owners value providing their animals with comprehensive healthcare. An appealing incentive is the availability of insurance policies and wellness programs that cover treatment for obesity, joint discomfort, & other conditions. In addition, the establishment of specialized veterinary clinics and hospitals offering orthopedic services, such as surgery and rehabilitation, has been on the rise in Dubai, UAE, contributing to the adoption of orthopedic medicines & therapies.

Key Veterinary Orthopedic Medicines Company Insights

Major companies are employing a diverse range of strategic initiatives to expand their market presence. These tactics include market expansions, mergers and acquisitions, partnerships, product launches, and collaborations. This multifaceted approach enables them to gain market share and solidify their position within competitive industries.

Some of the key players operating in the market are Zoetis Inc; Boehringer Ingelheim; Elanco Animal Health, Inc.; and Merck Animal Health (Merck & Co. Inc). Industry leaders like Zoetis, Inc.; Boehringer Ingelheim; Elanco Animal Health; American Regent, Inc.; Merck Animal Health (Merck & Co. Inc); and Vetoquinol S.A. are investing significantly in the R&D of novel medicines for musculoskeletal complications prevalent in various animals. Companies like Ardent Animal Health, LLC; VetStem, Inc.; and MEDREGO LLC are focusing on developing specialized biologics like stem cells, PRP, and other biologics to effectively combat orthopedic conditions in animals.

• Zoetis is one of the leading veterinary product companies in the world. It discovers, develops, manufactures, and commercializes vaccines, medicines, diagnostics, & other technologies for the treatment of various diseases in companion animals, as well as livestock animals. It has a widespread network in over 45 countries.
• Elanco Animal Health has operated in the veterinary industry for over 65 years. It is a subsidiary of the pharmaceutical products giant Elli Lilly & Company. The company is among the top four global veterinary product manufacturers, with over 200 brands and a presence in over 90 countries.

Hyalogic, Bioiberica S.A.U, and Contipro A.S. are some of the emerging market participants in the veterinary orthopedic medicines market.

• Hyalogic is a company that specializes in and focuses on manufacturing products made from high-molecular-weight hyaluronic acid, which has hydrating and lubricating properties. Its product portfolio includes skin care, personal care, joint care, etc., for humans and specialized joint care products for animals.

Key Veterinary Orthopedic Medicines Companies

The following key companies have been profiled for this study on the Veterinary Orthopedic Medicines Market:

• Zoetis Inc.

• Boehringer Ingelheim International GmbH

• Elanco Animal Health Incorporated

• American Regent, Inc.

• Merck Animal Health

• Vetoquinol S.A.

• Ceva Santé Animale

• Virbac

• Biogénesis Bagó S.A.

• Ardent Animal Health, LLC

• Bioiberica S.A.U.

• PetVivo Holdings, Inc.

• Contipro a.s.

• VetStem, Inc.

• Enso Discoveries, LLC

• Contura Vet US

• T-Cyte Therapeutics, Inc.

• Medrego LLC

• Bimeda, Inc.

• Hester Biosciences Limited

Recent Developments

• In April 2024, VetStem, Inc. launched PrecisePRP Canine, an off-the-shelf PRP product designed for intra-articular administration in dogs. This freeze-dried PRP requires no blood draw or centrifugation, offering consistent dosage and reduced safety risks through FDA-approved quality testing.
• In April 2024, Felix Pharmaceuticals Pvt. Ltd. received FDA approval for ANADA (Carprofen), which is used for treating pain & inflammation caused by OA and managing pain that results from orthopedic & soft tissue surgeries in dogs.

Global Veterinary Orthopedic Medicines Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends and opportunities in each sub segment from 2021 to 2033. For this study, Grand View Research has segmented global Veterinary Orthopedic Medicines Market report on the basis of product, animal type, application, route of administration, end use, and region.

• Product Outlook (Revenue, USD Billion, 2021 - 2033)

  • • Biologics

      • Stem Cells

      • Platelet-Rich Plasma (PRP)

      • Other Biologics

    • Viscosupplements

    • Pharmaceuticals

      • Steroids

      • NSAIDS

      • Others

  • Animal Type Outlook (Revenue, USD Billion, 2021 - 2033)

    • Canine

    • Equine

    • Others

• Application Outlook (Revenue, USD Billion, 2021 - 2033)

  • Osteoarthritis

  • Degenerative Joint Disease

  • Other Applications

• Route of Administration Outlook (Revenue, USD Billion, 2021 - 2033)

  • Oral

  • Injectable

    • Intra-muscular

    • Intra-articular

  • Others

• End Use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Veterinary Hospitals

  • Veterinary Clinics

  • Others

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait